RADNOR, Pa., Sept. 13, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and life-threatening infectious diseases, will be presenting at the UBS Global Life Sciences Conference. The Conference will take place September 19-21, 2011 at the Grand Hyatt in New York, NY.
